Liang Chen

Dr. Liang Chen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022
Verified
Journal Article
Closed access
JGJiahua Guo
Jiahua Guo
YZYu Zhang
Yu Zhang
LCLiyuan Chen
Liyuan Chen
LXLiming Xu
Liming Xu
Xiumei MoXiumei Mo
Xiumei Mo
LCLiang Chen
Liang Chen

18 April 2026
Verified
Book Chapter
Closed access
PDF file
XGXiaolei Guo
Xiaolei Guo
LCLiang Chen
Liang Chen
QDQian Dong
Qian Dong
JTJinglong Tang
Jinglong Tang
WLWEI LAN
WEI LAN
YTYingying Teng
Yingying Teng

Verified
Journal Article
Open access
PDF file
XHXuemeng He
Xuemeng He
MGMenghang Guo
Menghang Guo
HLHuan Lian
Huan Lian
LCLiang Chen
Liang Chen
Osteoarthritis (OA) is a chronic degenerative joint disorder characterized primarily by cartilage degradation and extensive inflammation. Its pathological progression is closely associated with the dysregulation of critical signaling pathways; consequently, the therapeutic targets of these pathways have become crucial for intervening underlying mechanisms of cartilage damage. Extensive laboratory studies have found that mesenchymal stem cell-derived exosomes (MSC-Exos) can deliver bioactive cargoes such as microRNAs (miRNAs) and antioxidant enzymes to modulate these targets, thereby exerting therapeutic effects that include mitigating inflammation, inhibiting chondrocyte apoptosis, maintaining extracellular matrix homeostasis, and promoting tissue repair. However, the clinical translation of MSC-Exos is significantly hampered by inherent limitations, including source variability, low stability, and rapid clearance from the joint cavity. Hydrogels, recognized for their excellent biocompatibility, three-dimensional biomimetic architecture, and controlled drug release capabilities, have been used for OA therapy. Therefore, this review summarizes current research on the combined application of exosomes and hydrogels for OA treatment, and proposes optimization strategies for exosome preconditioning, hydrogel material selection, and hydrogel functional design. These strategies aim to enhance exosome functionality as well as enable sustained responsive, and localized exosome release within the joint, thereby improving the therapeutic efficacy for OA.